|
Hyperpolarized [1-13C] pyruvate (HP 13C) Clinical Trials
1 actively recruiting trial across 1 location
Also known as: Hyperpolarized 13C
San Francisco, California1 trial
Hyperpolarized (HP) 13C Pyruvate Magnetic Resonance Imaging (MRI) for Response Monitoring to Neoadjuvant Abiraterone
University of California, San Francisco
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.